Cimafranca, Ana Flor .

HRN: 28-33-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/16/2026
03/16/2026
IVT
1g
SD
Stat CS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines